The pooled hazard ratios indicated a statistically significant risk of a lower 5 year overall survival rate for CCR7+ vs. CCR7− gastric cancers (HR = 0.46, 95% CI 0.31–0.70. This evidence concerns the gene CCR7 and gastric cancer.